1. Home
  2. CRNX vs SLM Comparison

CRNX vs SLM Comparison

Compare CRNX & SLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.97

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo SLM Corporation

SLM

SLM Corporation

HOLD

Current Price

$22.25

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
SLM
Founded
2008
1972
Country
United States
United States
Employees
N/A
1788
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.2B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CRNX
SLM
Price
$33.97
$22.25
Analyst Decision
Strong Buy
Buy
Analyst Count
8
11
Target Price
$76.75
$31.09
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
2.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,039,000.00
N/A
Revenue This Year
$720.10
$3.35
Revenue Next Year
$184.67
$5.68
P/E Ratio
N/A
$6.91
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$17.77
52 Week High
$57.99
$34.25

Technical Indicators

Market Signals
Indicator
CRNX
SLM
Relative Strength Index (RSI) 40.12 52.96
Support Level $33.36 $20.88
Resistance Level $37.23 $22.86
Average True Range (ATR) 1.36 0.55
MACD -0.23 0.04
Stochastic Oscillator 29.09 74.67

Price Performance

Historical Comparison
CRNX
SLM

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About SLM SLM Corporation

SLM Corp is an education solutions company. Its business is to originate and service loans to students and their families to finance the cost of their education. The term' Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.

Share on Social Networks: